当前位置: X-MOL 学术Clin. Gastroenterol. Hepatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: A Multicenter Cohort Study
Clinical Gastroenterology and Hepatology ( IF 11.6 ) Pub Date : 2024-11-05 , DOI: 10.1016/j.cgh.2024.09.034
Guillaume Le Cosquer, Julien Kirchgesner, Cyrielle Gilletta De Saint Joseph, Philippe Seksik, Aurélien Amiot, David Laharie, Maria Nachury, Cléa Rouillon, Vered Abitbol, Alexandre Nuzzo, Stéphane Nancey, Mathurin Fumery, Amélie Biron, Nicolas Richard, Romain Altwegg, Driffa Moussata, Benedicte Caron, Mathias Vidon, Catherine Reenaers, Mathieu Uzzan, Jean-Marie Reimund, Mélanie Serrero, Marion Simon, Alban Benezech, Félix Goutorbe, Anne-Laure Pelletier, Ludovic Caillo, Charlotte Vaysse, Florian Poullenot, GETAID, Barbara Bournet, Samira Denguir, Frank Zerbib, Pauline Rivière, Charlotte Gagnière, Julie Assaraf, Guillaume Cadiot, Hedia Brixi, Guillaume Savoye, Clara Yzet, Franck Brazier, Laurent Peyrin-Biroulet, Mellie Heinemann, Nicolas Vigneron, Marie Coisnon, Justine Amaro, Mira Raad, Charlotte Mailhat

Breast cancer is the most common malignancy observed in patients with inflammatory bowel diseases (IBD). The aim of our study was to evaluate incident cancer rate (recurrence or new-onset cancer) in a cohort of patients with IBD with a history of breast cancer according to the subsequent IBD treatment provided.

中文翻译:


既往乳腺癌炎症性肠病患者发生癌症的风险:一项多中心队列研究



乳腺癌是炎症性肠病 (IBD) 患者中最常见的恶性肿瘤。我们研究的目的是根据提供的后续 IBD 治疗评估一组有乳腺癌病史的 IBD 患者队列的发病率(复发或新发癌症)。
更新日期:2024-11-05
down
wechat
bug